1. Glenmark Life Science
stock logo

75% Buy

Glenmark Life Science Share Price

GLS

₹808.90-₹8.25 (-1.01%) Past Year
₹802.00₹825.00
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

About

arrow

Market cap

Market Cap Switch₹10,743 Cr

Open

₹825.00

Close

₹817.15

Circuit range

₹898.85 - ₹735.45

Day range

₹802.00 - ₹825.00

Year range

₹397.35 - ₹906.00

Volume

45,200

Avg. traded

₹813.02

Revenue (12m)

₹2,368 Cr

Glenmark Life ScienceGlenmark Life Sciences Limited is an India-based company that is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients (API). The Company’s product portfolio comprises of various therapeutic segments, which include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, gastrointestinal health, oncology, pain management and anti-infectives. Its products include Adapalene, Alogliptin Benzoate, Amiodarone HCl, Esomeprazole Sodium, Eszopiclone, Etoricoxib, Omeprazole, Oxcarbazepine, Zolpidem Tartrate, Zonisamide and Voriconazole. The Company’s products also include Vildagliptin, Aprepitant, Bosentan, Cilostazol, Deferasirox, Fluconazole, Ivacaftor, Pirfenidone, Riluzole, Sucralfate, Ticagrelor, Telmisartan and Umifenovir. The Company’s research and development facilities are located at Mahape, Ankleshwar and Dahej in India and manufacturing facilities are located at Ankleshwar, Dahej, Mohol and Kurkumbh.

Read more

Glenmark Life Science Key indicators

arrow

52 week high

₹906.00

52 week low

₹397.35

P/E ratio

19.26

P/B ratio

3.98

ROE

22.33%

ROCE

30.01%

Dividend yield

2.57%

Debt/Equity ratio

EPS

38.11

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

75%

Hold

25%

Sell

0%

This analysis is based on the reviews of 4 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

30.89%

Net profit margin

21.49%

ROE

22.33%

ROA

15.43%

ROCE

30.01%

Learn more

Glenmark Life Science Shareholder returns

arrow

1 day

+0.47%

1 week

+2.53%

1 month

+6.75%

3 months

+9.65%

1 year

+99.96%

3 years

+9.17%

5 years

+9.17%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Cash flow

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Balance sheet

All values are in ₹ Crores (Cr)
arrow
Empty state

No data available at the moment

Glenmark Life Science Share Price history

arrow
DayOpenCloseDay’s change
Wed, Apr 10 2024
₹817.00
₹817.15
+0.02%
Tue, Apr 9 2024
₹815.00
₹813.30
-0.21%
Mon, Apr 8 2024
₹817.30
₹810.50
-0.84%
Fri, Apr 5 2024
₹816.00
₹817.30
+0.16%
Thu, Apr 4 2024
₹814.90
₹815.35
+0.06%
Wed, Apr 3 2024
₹790.10
₹797.00
+0.87%
Tue, Apr 2 2024
₹790.00
₹790.65
+0.08%
Mon, Apr 1 2024
₹790.95
₹785.05
-0.75%

Shareholding info

arrow

Promoters (82.85%)

Mutual Funds (0.59%)

Retail and other (11.84%)

Foreign institutions-FII (4.57%)

Other domestic institutions (0.15%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹22.5/share

    Ex date 17 Oct 2023

    expand tab
  • Dividend • ₹21/share

    Ex date 24 Mar 2023

    expand tab
  • Dividend • ₹10.5/share

    Ex date 15 Sep 2022

    expand tab
  • Dividend • ₹10.5/share

    Ex date 22 Nov 2021

    expand tab

Learn more

Frequently asked questions